Monitoring TB program performance

Int J Tuberc Lung Dis. 2022 Jul 1;26(7):692-693. doi: 10.5588/ijtld.22.0194.

Authors

C A Basham¹, P H Orr²

Affiliations

¹ Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women´s Hospital, Boston, MA, USA.
² Departments of Internal Medicine, Community Health Sciences, and Medical Microbiology, University of Manitoba, Winnipeg, MB, Canada.

PMID: 35768927
DOI: 10.5588/ijtld.22.0194

No abstract available

Publication types

Letter
Comment

MeSH terms

Humans
Program Evaluation
Tuberculosis* / diagnosis
Tuberculosis* / epidemiology
Tuberculosis* / prevention & control